List of AdipoGen Life Sciences’ validated recombinant proteins for ACE2 & COVID-19 research
Validated Recombinant Proteins for ACE2 & COVID-19 Research
New SARS-CoV-2 Recombinant Antibodies
List of AdipoGen Life Sciences’ SARS-CoV-2 recombinant antibodies
NEW Active & Stable Trimeric SARS-CoV-2 Protein – Adipogen
AdipoGen’s SARS-CoV-2 Spike Protein (D614G) (Stable Trimer) (rec.) (His) is a full-length soluble SARS-CoV-2 Spike protein.
New ACE2 (human) ELISA Kit
Adipogen has developed a sensitive and specific colourimetric sandwich ACE2 (human) ELISA Kit.
Highly Specific SARS-CoV-2 Neutralising Antibodies Detection Kit
AdipoGen Life Sciences has developed a sensitive, specific, and fast SARS-CoV-2 Neutralising Antibodies Detection Kit.
What is a Pseudovirus? – ProSci Inc.
It has been two years since the outbreak of coronavirus disease 2019 (COVID-19). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the cause of the pandemic and has only gotten more complex for scientists to study. Studies of
Human MHC Class II QuickSwitch™ Platform is used to Identify SARS-CoV-2 Virus Derived Peptides
In a previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) MBL International described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and determining whether that
How to Identify SARS-CoV-2 Virus Derived Peptides
In a previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research), MBL International describes how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and determining whether
Find Human MHC Class I Dominant Peptides
In a previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) MBL International described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and determining whether
Comparing Theoretical Peptide-MHC Binding Affinity to Real Values produced by the QuickSwitch™ Platform
In a previous blog post (How to screen SARS-CoV-2 peptides to facilitate T cell research) MBL International described how the immune system samples all of the pathogenic proteins by looking at the small fragments of each protein and determining whether